• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec10
Galore Pharmaceutical's ASC40 New Drug Application for Acne Treatment Accepted by NMPA
09:02
Dec8
Greasy Pharmaceutical Announces Positive Results from ASC30 Phase II Clinical Trial
09:31
Galore Pharmaceutical-B's New Drug Denifanstat Receives Marketing Authorization Application Acceptance
05:46
Dec3
Gallant Biopharm repurchased 1.306 million shares for HKD 15.9275 million
09:24
Nov11
Galore Pharmaceuticals-B Selects ASC36 as Clinical Development Candidate
07:23
Nov5
GALY Pharma-B repurchases 100,000 shares at a cost of HKD 9.24 million
11:02

Schedules & Filings

Schedules
Filings
Aug15
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 591.59 K, Net Income -48.13 M, EPS -0.05

Gere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference CallGere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference Call
Mar26
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 682.46 K, Net Income -90.76 M, EPS -0.0919

Aug30
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -70.02 M, EPS -0.0688

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08413
0.208
+80.87%
+0.093
08186
0.720
+51.58%
+0.245
02135
0.188
+37.23%
+0.051
00209
0.184
+24.32%
+0.036
01239
0.390
+23.81%
+0.075
01371
0.290
+20.83%
+0.050
02971
0.012
+20.00%
+0.002
02227
0.189
+19.62%
+0.031
06958
0.135
+17.39%
+0.020
00768
0.045
+15.38%
+0.006
View More